A post-market study has been conducted by the Brånemark Clinic in Gothenburg on Artelon Cosmetic for soft tissue augmentation in the upper jaw. The study confirms that patients with tissue defects can be treated successfully with Artelon Cosmetic.
Dr. Bertil Friberg, who conducted the study at the Brånemark Clinic, states: “Artelon is an interesting material for dental applications. In this particular study we demonstrate that Artelon Cosmetic integrates well with body tissue and volume augmentation is maintained over time.”
Hans Rosén comments: “The results of the study are very encouraging. Artimplant’s operating focus is orthopedics and consequently we have decided not to expand our own sales in the dental area, but we do have professionals from the dentist west palm beach fl that are willing to help you. We are therefore investigating other business alternatives for Artelon Cosmetic.”
Artimplant (STO:ARTIB) (www.artimplant.com)
Artimplant’s mission is to restore the health of patients by offering medical professionals degradable implants that help the body to heal. Artimplant is a medical technology company that restores health through the development, production and marketing of degradable implants that regenerate body functions and improve quality of life. Our products are made from Artelon, a biomaterial developed by the Company. Artimplant produces implants for the treatment of osteoarthritis and the reinforcement of weakened soft tissue. The Company’s products are sold through licensees and own sales under the Artimplant brand take place through agents and distributors. Artimplant is a public company listed on the NASDAQ OMX Stockholm Exchange in the Small Cap segment and in the Healthcare sector.